Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Rhythm Pharmaceuticals, Raises Price Target to $16

Morgan Stanley Maintains Equal-Weight on Rhythm Pharmaceuticals, Raises Price Target to $16

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Equal-Weight and raises the price target from $8 to $16.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Equal-Weight and raises the price target from $8 to $16.

Long-Dormant Ethereum Address Comes To Life After 8.5 Years Amid Growing Speculation Of ETH ETF

By Mehab Qureshi

January 15, 3:05 AM

An Ethereum (CRYPTO: ETH) address that stood inactive for eight and a half years sprang to life as it transferred 2000 ETH, worth approximately $506,140, Etherscan data confirms.

BTC

Avangrid and Statkraft Establish U.S. Relationship with Virtual Power Purchase Agreement

By Benzinga Newsdesk

April 8, 12:03 PM

Statkraft to receive Renewable Energy Certificates (RECs) from Avangrid's 300 MW Streator Cayuga Ridge South Wind FarmVPPAs are financial agreements for RECs tied to the amount of renewable energy produced by the

AGR